Philips has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Rembra platform of CT and radiation therapy systems.
These include the Rembra CT for diagnostic imaging and Rembra RT and Areta RT for radiation therapy planning.
Rembra CT features an 85-cm bore and is designed for high-throughput imaging in emergency, critical care, and interventional settings, supporting up to 270 exams per day, according to Philips.
Rembra RT and Areta RT are designed for radiation therapy simulation and planning, featuring an 85-cm extended field of view and next-generation 4D CT imaging capabilities to support tumor targeting while helping protect healthy tissue.
The three systems together are intended to span diagnostic radiology and radiation therapy planning within a unified CT platform.
